Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | plasmid | stable transfection | DOTAP | publication | P. Lau et al., J. Biol. Chem., Aug 2004; 279: 36828 - 36840 | ||
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | plasmid | stable transfection | Metafectene | publication | M. A. Maxwell et al., J. Biol. Chem., Apr 2005; 280: 12573 - 12584 | Link | |
C2C12 |
Mouse myoblast cell line | ATCC CRL-1772 | Mouse | muscle | cell line | adherent | plasmid | stable transfection | Metafectene | publication | P. Lau et al., J. Biol. Chem., Aug 2004; 279: 36828 - 36840 | ||
C4-2 |
Human prostate carcinoma cell line (derivative of LNCaP) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R.C. Peery, Dissertation,, 2020, Indiana University | Link | ||
CHO |
Chinese hamster ovary cell line | Hamster | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. Kotarsky et al., J. Pharmacol. Exp. Ther., Aug 2006; 318: 619 - 628. | Link | ||
CHO |
Chinese hamster ovary cell line | Hamster | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | publication | N. Azzam et al., Endocrinology, 2012, 153 (2): 954–960, doi: 10.1210/en.2011-1856 | |||
CHO |
Chinese hamster ovary cell line | Hamster | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene | application note | ![]() |
|||
CM7/1 |
Mouse embryonic stem cell line | Mouse | unknown | stem cell | adherent | plasmid | stable transfection | Metafectene PRO | publication | D. Weber, Doctoral Thesis, 2014, Julius-Maximilians-Universitaet Wuerzburg | Link | ||
COS-7 |
African green monkey kidney fibroblast-like cell line | ATCC CRL 1651 | Monkey | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | V. Thieme et al., British J. of Pharmacology, 2016, 173:3208-3221; DOI:10.1111/bph.13582 | Link | |
DLD-1 |
Human colon adenocarcinoma cell line | ATCC CCL-221 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | C. Emming, Dissertation, 2021, Ludwig-Maximilians-Universität München | Link | |
EFO-27 |
Human ovary adenocarcinoma cell line (cisplatin resistant) | Human | genital tract | cell line | adherent | plasmid | stable transfection | K2 Transfection System | application note | ![]() |
|||
ESC |
Murine ESCs of the line R1 | Murine | unknown | stem cell | adherent | plasmid | stable transfection | Metafectene | publication | A. K. Shakhbazyan et al., Russian J. of Developmental Biol., 2013, 44 (6): 302–306, DOI: 10.1134/S1062360413060088 | |||
Flp-In 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene | publication | S. M. Hoser et al., Genome Biology, 2020, 21: 299, doi.org/10.1186/s13059-020-02199-6 | Link | ||
Flp-In T-REx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | N.E. Taboko, Masters Thesis, 2020, UiT Norges arktiske universitet | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
FTC-133 |
Human follicular thyroid carcinoma/lymph node metastasis cell line | ECACC 94060901 | Human | other | cell line | adherent | plasmid | stable transfection | Metafectene | publication | J. Pyka et al., Cancer Res., Feb 2005; 65: 1343 - 1351 | Link | |
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
GL15 |
Human glioblastoma cell line | Human | brain | cell line | adherent | plasmid | stable transfection | Metafectene | publication | R. Xie et al., Oncology Reports, 2013, 29: 177-184, 2013, DOI: 10.3892/or.2012.2102 | Link | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | A.-K. Schmidt et al., bioRxiv preprint, 2021, doi.org/10.1101/2021.10.11.463929 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | L. Ramapathiran et al., J. Cell Sci., Feb 2014; 127: 609 - 619 | Link | |
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Arechederra et al., J. Biol. Chem., Feb 2015; 290: 4383 - 4397 | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene | publication | K. Berger, Georg-August-Universität Göttingen | Link |